Hypoxia-Inducible Factor-Proline Dioxygenases
"Hypoxia-Inducible Factor-Proline Dioxygenases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Dioxygenase enzymes that specifically hydroxylate a PROLINE residue on the HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT. They are OXYGEN-dependent enzymes that play an important role in mediating cellular adaptive responses to HYPOXIA.
| Descriptor ID |
D064799
|
| MeSH Number(s) |
D08.811.682.690.416.617.500 D08.811.682.690.708.694.500
|
| Concept/Terms |
Hypoxia-Inducible Factor-Proline Dioxygenases- Hypoxia-Inducible Factor-Proline Dioxygenases
- Dioxygenases, Hypoxia-Inducible Factor-Proline
- Factor-Proline Dioxygenases, Hypoxia-Inducible
- Hypoxia Inducible Factor Proline Dioxygenases
- HIF Prolyl-4-Hydroxylases
- HIF Prolyl 4 Hydroxylases
- Prolyl-4-Hydroxylases, HIF
- Hypoxia-Inducible Factor-Proline Dioxygenase
- Dioxygenase, Hypoxia-Inducible Factor-Proline
- Factor-Proline Dioxygenase, Hypoxia-Inducible
- Hypoxia Inducible Factor Proline Dioxygenase
- HIF Prolyl-4-Hydroxylase
- HIF Prolyl 4 Hydroxylase
- Prolyl-4-Hydroxylase, HIF
|
Below are MeSH descriptors whose meaning is more general than "Hypoxia-Inducible Factor-Proline Dioxygenases".
Below are MeSH descriptors whose meaning is more specific than "Hypoxia-Inducible Factor-Proline Dioxygenases".
This graph shows the total number of publications written about "Hypoxia-Inducible Factor-Proline Dioxygenases" by people in this website by year, and whether "Hypoxia-Inducible Factor-Proline Dioxygenases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypoxia-Inducible Factor-Proline Dioxygenases" by people in Profiles.
-
Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD). Kidney Int. 2026 Jan; 109(1):44-56.
-
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 10; 104(4):655-680.
-
PHDs/CPT1B/VDAC1 axis regulates long-chain fatty acid oxidation in cardiomyocytes. Cell Rep. 2021 10 05; 37(1):109767.
-
Depletion of Endothelial Prolyl Hydroxylase Domain Protein 2 and 3 Promotes Cardiomyocyte Proliferation and Prevents Ventricular Failure Induced by Myocardial Infarction. Circulation. 2019 07 30; 140(5):440-442.
-
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. Cancer Res. 2019 05 01; 79(9):2327-2338.
-
Prolyl Hydroxylase Domain-2 Protein Regulates Lipopolysaccharide-Induced Vascular Inflammation. Am J Pathol. 2019 01; 189(1):200-213.
-
Hypoxia inducible factor-1a mediates the profibrotic effect of albumin in renal tubular cells. Sci Rep. 2017 Nov 20; 7(1):15878.
-
PHD2/3-dependent hydroxylation tunes cardiac response to ?-adrenergic stress via phospholamban. J Clin Invest. 2015 Jul 01; 125(7):2759-71.
-
PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response. J Clin Invest. 2012 Aug; 122(8):2827-36.
-
Metabolic insight into mechanisms of high-altitude adaptation in Tibetans. Mol Genet Metab. 2012 Jun; 106(2):244-7.